May Guo
Chief Commercial Officer Areterna
Seminars
Tuesday 22nd July 2025
The Usage of CAP5011 & CAP1811 in mRNA Vaccines & Cancer Immunotherapies
4:00 pm

Chief Commercial Officer Areterna